Skip to main content

Displaying 1 - 20 of 129

Nordic Clinical, Inc. and Encore Plus Solutions, Inc.

In April 2020, the marketers of three supplements called Neurocet, Regenify, and Resetigen-D settled FTC charges that they deceptively promoted their products to older Americans using false claims that their products could stop pain and treat age-related ailments. The proposed order bars the defendants—five related companies and their principals from making any claims about the health benefits of their products unless they are true and supported by scientific evidence. In October 2021, the FTC announced it was returning $1.1 million to consumer who bought the defendants’ products.

Type of Action
Federal
Last Updated
FTC Matter/File Number
172 3132
172 3143
Case Status
Pending

Quickwork LLC and Eric A. Nepute

In April 2021, the FTC charged St. Louis-based chiropractor Eric Anthony Nepute and his company Quickwork LLC with violating the COVID-19 Consumer Protection Act and the Federal Trade Commission Act, by deceptively marketing products containing vitamin D and zinc as scientifically proven to treat or prevent COVID-19. This is the first such case in which the agency has sought civil penalties.

Type of Action
Federal
Last Updated
FTC Matter/File Number
202 3188
Case Status
Pending